mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.03 |
mRNA |
paclitaxel |
CCLE |
pan-cancer |
AAC |
0.099 |
0.04 |
mRNA |
MST-312 |
CTRPv2 |
pan-cancer |
AAC |
-0.075 |
0.04 |
mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.04 |
mRNA |
Parthenolide |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.04 |
mRNA |
BRD-M00053801 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.04 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.063 |
0.04 |
mRNA |
Axitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.04 |
mRNA |
BRD-K79669418 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.04 |
mRNA |
dabrafenib |
GDSC1000 |
pan-cancer |
AAC |
-0.062 |
0.04 |